4:01 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Lantern Pharma Nasdaq/NYSE Compliance Notice
Lantern Pharma Inc. received a deficiency notice from Nasdaq on September 25, 2026, for failing to maintain a minimum market value of listed securities (MVLS) of $35 million for 30 consecutive business days. The company has 180 calendar days, or until March 24, 2027, to regain compliance by maintaining an MVLS of at least $35 million for 10 consecutive business days.
- Counterparty
- Nasdaq
- Term
- 180 days